当前位置: X-MOL 学术Diabetes Obes. Metab. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Liraglutide reduces cardiac adipose tissue in type 2 diabetes: A secondary analysis of the LIRAFLAME randomized placebo-controlled trial
Diabetes, Obesity and Metabolism ( IF 5.4 ) Pub Date : 2021-08-13 , DOI: 10.1111/dom.14516
Ida K.B. Rasmussen 1 , Emilie H. Zobel 1 , Rasmus S. Ripa 2, 3 , Bernt J. von Scholten 1, 4 , Viktor R. Curovic 1 , Jacob K. Jensen 2, 3 , Andreas Kjaer 2, 3 , Tine W. Hansen 1 , Peter Rossing 1, 3
Affiliation  

To test the hypothesis that treatment with liraglutide can reduce cardiac adipose tissue.

中文翻译:

利拉鲁肽减少 2 型糖尿病患者的心脏脂肪组织:LIRAFLAME 随机安慰剂对照试验的二次分析

检验利拉鲁肽治疗可以减少心脏脂肪组织的假设。
更新日期:2021-08-13
down
wechat
bug